Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands
Top Cited Papers
- 1 January 2001
- journal article
- review article
- Published by Elsevier BV in The Lancet
- Vol. 357 (9251), 165-168
- https://doi.org/10.1016/s0140-6736(00)03587-x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Familial hypercholesterolemia: potential diagnostic value of mutation screening in a pediatric population of South AfricaClinical Genetics, 2008
- Additional risk factors influence excess mortality in heterozygous familial hypercholesterolaemiaAtherosclerosis, 2000
- Molecular genetic testing for familial hypercholesterolemia: spectrum of LDL receptor gene mutations in the NetherlandsClinical Genetics, 2000
- Molecular biology of arrhythmic syndromesCurrent Opinion in Cardiology, 2000
- Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical managementAtherosclerosis, 1999
- Cholesterol Reduction Yields Clinical BenefitCirculation, 1998
- Neonatal Diagnosis of Familial Hypercholesterolemia in Newborns Born to a Parent With a Molecularly Defined Heterozygous Familial HypercholesterolemiaArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Total and HDL-Cholesterol in The Netherlands: 1987–1992. Levels and Changes over Time in Relation to Age, Gender and Educational LevelInternational Journal of Epidemiology, 1994
- Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular geneticsThe American Journal of Cardiology, 1993
- Diagnosing familial hypercholesterolaemia in childhood by measuring serum cholesterol.BMJ, 1977